Xian-lin Wu
Shenzhen, 518000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Icariside II sensitizes osteosarcoma to doxorubicin through the lincROR/Wnt/β-catenin signaling regulatory axis.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: July 21, 2025
Corrigendum to "Polydatin sensitizes osteosarcoma cells to methotrexate through suppressing the H19/H3K27me3/H3K9me3 mediated folate metabolism regulatory axis" [Bioorg. Chem. 162 (2025) 108583].
Journal: Bioorganic chemistry
Published: June 18, 2025
Polydatin sensitizes osteosarcoma cells to methotrexate through suppressing the H19/H3K27me3/H3K9me3 mediated folate metabolism regulatory axis.
Journal: Bioorganic chemistry
Published: February 27, 2025
5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1/SLC7A11-mediated ferroptosis.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: September 06, 2024
Tiliroside induces ferroptosis to repress the development of triple-negative breast cancer cells.
Journal: Tissue & cell
Published: March 20, 2023
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response.
Journal: Signal transduction and targeted therapy
Published: April 15, 2022
The inducible effect of LBP on maturation of dendritic cells and the related immune signaling pathways in hepatocellular carcinoma (HCC).
Journal: Current drug delivery
Published: November 30, 2011
The suppression effects of desacetyluvaricin on hepatocellular carcinoma and its possible mechanism.
The suppression effects of desacetyluvaricin on hepatocellular carcinoma and its possible mechanism.
Journal: Pharmacognosy magazine
Published: November 03, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026